Peptide-based immunotherapeutic agent for treating allergic diseases
AssigneeMeiji Milk Products Co., Ltd.
InventorsToshio Sone, Akinori Kume, Kazuo Dairiki, Akiko Iwama, Kohsuke Kino
Life of this patent
Estimating the term…
Abstract
The present invention provides a monomolecular multi-epitope peptide prepared by binding T cell epitope regions derived from different allergen molecules with each other. A peptide-based immunotherapeutic agent containing an effective amount of the multi-epitope peptide can treat a wide range of allergic diseases.
Claims11
A peptide-based immunotherapeutic agent comprising the amino acid sequence of SEQ ID NO:
- 1.
A peptide-based immunotherapeutic agent comprising the amino acid sequence of SEQ ID NO:
- 2.
A peptide-based immnunotherapeutic agent comprising the amino acid sequence of SEQ ID NO:
- 3.
A method of treating cedar pollinosis comprising the administration of a composition comprising a pharmaceutically acceptable carrier or diluent or diluent and a peptide-based immunotherapeutic agent comprising an amino acid sequence selected from the group consisting of SEQ ID NO:
- 1, 2, and 3.
A composition comprising a pharmaceutically acceptable carrier or diluent and a peptide-based immunotherapeutic agent comprising an amino acid sequence selected from the group consisting of SEQ ID NO:
- 1, 2, and 3.
Dependencies are inferred from the claim text.